Stem cell therapy(University of Sydney)

N/A

Report date: 2024/09/19 17:35:13

Base Information

Drug NameStem cell therapy(University of Sydney)
Drug Alias NameCYP-004
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy
Mechanisms of ActionStem cell replacements
TargetsUpdating
Therapy Area/IndicationsOsteoarthritis, KneeOsteoarthritis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesUniversity of Sydney
China Registration ClassN/A

Develop Information

Active CompaniesUniversity of SydneyCynata Therapeutics Ltd
Inactive CompaniesN/A
Active IndicationsOsteoarthritis, KneeOsteoarthritis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A